{"title":"荨麻疹和血管性水肿(荨麻疹)的最新情况。","authors":"R W Fox","doi":"10.2500/108854195778667837","DOIUrl":null,"url":null,"abstract":"<p><p>The update on urticaria involves new concepts on the pathogenesis and the treatment of severe hives that are unresponsive to conventional treatments. A newly described autoantibody IgG against IgE receptor has been identified in some severe chronic urticaria patients. Anti-inflammatory and immunomodulating agents are being used with increasing frequency by academic faculty and other physicians in severe chronic idiopathic urticaria (CIU).</p>","PeriodicalId":7423,"journal":{"name":"Allergy proceedings : the official journal of regional and state allergy societies","volume":"16 6","pages":"289-92"},"PeriodicalIF":0.0000,"publicationDate":"1995-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2500/108854195778667837","citationCount":"9","resultStr":"{\"title\":\"Update on urticaria and angioedema (hives).\",\"authors\":\"R W Fox\",\"doi\":\"10.2500/108854195778667837\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The update on urticaria involves new concepts on the pathogenesis and the treatment of severe hives that are unresponsive to conventional treatments. A newly described autoantibody IgG against IgE receptor has been identified in some severe chronic urticaria patients. Anti-inflammatory and immunomodulating agents are being used with increasing frequency by academic faculty and other physicians in severe chronic idiopathic urticaria (CIU).</p>\",\"PeriodicalId\":7423,\"journal\":{\"name\":\"Allergy proceedings : the official journal of regional and state allergy societies\",\"volume\":\"16 6\",\"pages\":\"289-92\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1995-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2500/108854195778667837\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Allergy proceedings : the official journal of regional and state allergy societies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2500/108854195778667837\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy proceedings : the official journal of regional and state allergy societies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2500/108854195778667837","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The update on urticaria involves new concepts on the pathogenesis and the treatment of severe hives that are unresponsive to conventional treatments. A newly described autoantibody IgG against IgE receptor has been identified in some severe chronic urticaria patients. Anti-inflammatory and immunomodulating agents are being used with increasing frequency by academic faculty and other physicians in severe chronic idiopathic urticaria (CIU).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
